drugset / Trial / NCT06763926

Intranasal Nafarelin For Triggering Oocyte Maturation

NCT06763926

Phase 4 Not yet recruiting 154 enrolled Fundacion Dexeus
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a non-inferiority randomised, controlled clinical trial comparing subcutaneous triptorelin to intranasal nafarelin for the final maturation of oocytes in women undergoing fertility preservation cycles with oocyte cryopreservation undergoing ovarian stimulation.

Timeline

Start
2026-06-15
Primary completion
2028-01-15
Completion
2028-01-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nafarelin Other / unclassified 800 ug Intranasal
Comparator Triptorelin Other / unclassified 200 ug Subcutaneous

Indications

No indication recorded.